Category stocks

AbbVie Expects $67.6B Revenue

AbbVie forecasts Q2 2026 earnings AbbVie delivered strong Q2 2026 results, exceeding expectations. The company reported double-digit sales growth and advancement in its pipeline of innovative medicines. AbbVie forecasts 2026 adjusted EPS of $13.87-$14.07 and Q3